Page 1 of 51
ANCC PSYCHIATRIC MENTAL HEALTH NURSE PRACTITIONER
BOARD CERTIFICATION EXAM BANK: 100 QUESTIONS WITH
DETAILED RATIONALES
Nursing / Advanced Practice Psychiatric Nursing / psychopharmacology / psychotherapy
Exam coverage:
❖ Section 1 (Q1–20): Neurobiology, pathophysiology,
pharmacogenetics, and mechanisms of psychiatric disorders
and treatments.
❖ Section 2 (Q21–45): Clinical interviewing, mental status
exam, risk assessment, screening tools, and therapeutic
alliance.
❖ Section 3 (Q46–70): DSM-5-TR diagnosis,
psychopharmacology, and evidence-based treatment of
major psychiatric disorders.
❖ Section 4 (Q71–80): Psychotherapy principles, CBT, DBT, IPT,
family therapy, and motivational interviewing.
❖ Section 5 (Q81–100): Ethics, legal principles, cultural
competence, trauma-informed care, and professional role.
Section 1: Scientific Foundation (Questions 1–20)
, Page 2 of 51
Question 1
A PMHNP is reviewing the neurobiological underpinnings of
major depressive disorder. The provider understands that the
monoamine hypothesis, while incomplete, remains
foundational to understanding antidepressant action. Which of
the following best describes the core premise of the monoamine
hypothesis?
A. Depression results from an overabundance of serotonin in
the synaptic cleft.
B. Depression is caused by a deficiency of monoamine
neurotransmitters, including serotonin, norepinephrine, and
dopamine.
C. Depression is primarily caused by structural brain lesions in
the frontal lobe.
D. Depression results from excessive dopamine activity in the
mesolimbic pathway.
CORRECT ANSWER: B
RATIONALE: The monoamine hypothesis posits that depression
is caused by a deficiency of monoamine neurotransmitters
(serotonin, norepinephrine, and dopamine). Option A is
incorrect because the hypothesis suggests a deficiency, not an
overabundance. Option C is incorrect because structural
lesions are not the primary mechanism. Option D is incorrect
because excessive dopamine activity is associated with
psychosis, not depression.
, Page 3 of 51
Question 2
A patient presents with symptoms of psychosis, and the PMHNP
is considering the neurobiological basis of schizophrenia. The
provider understands that the dopamine hypothesis involves
which of the following pathways?
A. Hyperactivity of dopamine in the mesocortical pathway
B. Hyperactivity of dopamine in the mesolimbic pathway
C. Hypoactivity of dopamine in the nigrostriatal pathway
D. Hypoactivity of dopamine in the tuberoinfundibular pathway
CORRECT ANSWER: B
RATIONALE: The dopamine hypothesis of schizophrenia
suggests that positive symptoms (hallucinations, delusions) are
associated with hyperactivity of dopamine in the mesolimbic
pathway. Option A is incorrect because mesocortical
hypoactivity is associated with negative symptoms. Options C
and D are incorrect because nigrostriatal and
tuberoinfundibular pathways are associated with
extrapyramidal symptoms and prolactin regulation, respectively.
Question 3
A PMHNP is assessing a patient with anxiety. The provider
recalls that the amygdala plays a central role in fear processing.
Which of the following best describes the function of the
amygdala in anxiety disorders?
A. Regulation of respiratory rate
B. Detection of threat and initiation of fear responses
C. Coordination of voluntary movement
, Page 4 of 51
D. Regulation of body temperature
CORRECT ANSWER: B
RATIONALE: The amygdala is critical for detecting threats and
initiating fear responses, which are central to anxiety disorders.
Option A is incorrect because respiratory regulation involves the
brainstem. Option C is incorrect because voluntary movement
is coordinated by the motor cortex and cerebellum. Option D is
incorrect because body temperature is regulated by the
hypothalamus.
Question 4
A PMHNP is reviewing the pharmacokinetics of a medication.
The provider understands that the "first-pass effect" affects
which of the following?
A. The rate of drug absorption in the stomach
B. The metabolism of a drug by the liver before it reaches
systemic circulation
C. The excretion of a drug by the kidneys
D. The binding of a drug to plasma proteins
CORRECT ANSWER: B
RATIONALE: The first-pass effect refers to the metabolism of a
drug by the liver before it reaches systemic circulation, reducing
its bioavailability. Option A is incorrect because absorption
occurs in the gastrointestinal tract. Option C is incorrect
because excretion occurs primarily in the kidneys. Option D is
incorrect because protein binding affects distribution, not first-
pass metabolism.
ANCC PSYCHIATRIC MENTAL HEALTH NURSE PRACTITIONER
BOARD CERTIFICATION EXAM BANK: 100 QUESTIONS WITH
DETAILED RATIONALES
Nursing / Advanced Practice Psychiatric Nursing / psychopharmacology / psychotherapy
Exam coverage:
❖ Section 1 (Q1–20): Neurobiology, pathophysiology,
pharmacogenetics, and mechanisms of psychiatric disorders
and treatments.
❖ Section 2 (Q21–45): Clinical interviewing, mental status
exam, risk assessment, screening tools, and therapeutic
alliance.
❖ Section 3 (Q46–70): DSM-5-TR diagnosis,
psychopharmacology, and evidence-based treatment of
major psychiatric disorders.
❖ Section 4 (Q71–80): Psychotherapy principles, CBT, DBT, IPT,
family therapy, and motivational interviewing.
❖ Section 5 (Q81–100): Ethics, legal principles, cultural
competence, trauma-informed care, and professional role.
Section 1: Scientific Foundation (Questions 1–20)
, Page 2 of 51
Question 1
A PMHNP is reviewing the neurobiological underpinnings of
major depressive disorder. The provider understands that the
monoamine hypothesis, while incomplete, remains
foundational to understanding antidepressant action. Which of
the following best describes the core premise of the monoamine
hypothesis?
A. Depression results from an overabundance of serotonin in
the synaptic cleft.
B. Depression is caused by a deficiency of monoamine
neurotransmitters, including serotonin, norepinephrine, and
dopamine.
C. Depression is primarily caused by structural brain lesions in
the frontal lobe.
D. Depression results from excessive dopamine activity in the
mesolimbic pathway.
CORRECT ANSWER: B
RATIONALE: The monoamine hypothesis posits that depression
is caused by a deficiency of monoamine neurotransmitters
(serotonin, norepinephrine, and dopamine). Option A is
incorrect because the hypothesis suggests a deficiency, not an
overabundance. Option C is incorrect because structural
lesions are not the primary mechanism. Option D is incorrect
because excessive dopamine activity is associated with
psychosis, not depression.
, Page 3 of 51
Question 2
A patient presents with symptoms of psychosis, and the PMHNP
is considering the neurobiological basis of schizophrenia. The
provider understands that the dopamine hypothesis involves
which of the following pathways?
A. Hyperactivity of dopamine in the mesocortical pathway
B. Hyperactivity of dopamine in the mesolimbic pathway
C. Hypoactivity of dopamine in the nigrostriatal pathway
D. Hypoactivity of dopamine in the tuberoinfundibular pathway
CORRECT ANSWER: B
RATIONALE: The dopamine hypothesis of schizophrenia
suggests that positive symptoms (hallucinations, delusions) are
associated with hyperactivity of dopamine in the mesolimbic
pathway. Option A is incorrect because mesocortical
hypoactivity is associated with negative symptoms. Options C
and D are incorrect because nigrostriatal and
tuberoinfundibular pathways are associated with
extrapyramidal symptoms and prolactin regulation, respectively.
Question 3
A PMHNP is assessing a patient with anxiety. The provider
recalls that the amygdala plays a central role in fear processing.
Which of the following best describes the function of the
amygdala in anxiety disorders?
A. Regulation of respiratory rate
B. Detection of threat and initiation of fear responses
C. Coordination of voluntary movement
, Page 4 of 51
D. Regulation of body temperature
CORRECT ANSWER: B
RATIONALE: The amygdala is critical for detecting threats and
initiating fear responses, which are central to anxiety disorders.
Option A is incorrect because respiratory regulation involves the
brainstem. Option C is incorrect because voluntary movement
is coordinated by the motor cortex and cerebellum. Option D is
incorrect because body temperature is regulated by the
hypothalamus.
Question 4
A PMHNP is reviewing the pharmacokinetics of a medication.
The provider understands that the "first-pass effect" affects
which of the following?
A. The rate of drug absorption in the stomach
B. The metabolism of a drug by the liver before it reaches
systemic circulation
C. The excretion of a drug by the kidneys
D. The binding of a drug to plasma proteins
CORRECT ANSWER: B
RATIONALE: The first-pass effect refers to the metabolism of a
drug by the liver before it reaches systemic circulation, reducing
its bioavailability. Option A is incorrect because absorption
occurs in the gastrointestinal tract. Option C is incorrect
because excretion occurs primarily in the kidneys. Option D is
incorrect because protein binding affects distribution, not first-
pass metabolism.
